Delivery Order SPE2DR25D1106-SPE2DR26FJD3G
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,046.17 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of August 22, 2025. This is a firm fixed price, non-set-aside contract awarded competitively on August 21, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,037.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, awarded on November 28, 2025, with an ultimate completion date of December 1, 2025, represents a non-competed delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,208.18 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of November 26, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,107.97 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price, competitively awarded contract was executed on November 12, 2025, with an ultimate completion date of November 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $10,293.12 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $4,004.68 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vivitrol 380 mg vials with diluents. This firm fixed-price contract, designated as a non-competitive award with no set-aside designation, has an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $5,005.80. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,055.07 for VIVITROL 380 mg vials with diluents on December 2, 2025, with a completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJD3GDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This non-competitive delivery order, issued on December 11, 2025, utilizes firm fixed-price pricing with an ultimate completion date of December 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. Vivitrol is a long-acting opioid antagonist medication used for treating opioid addiction and alcohol use disorder, making this delivery order part of DLA's broader effort to support military and veteran healthcare systems with essential pharmaceuticals. AmerisourceBergen's extensive federal contracting history demonstrates its capability to fulfill specialized pharmaceutical requirements across multiple therapeutic domains. The company serves as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities through its comprehensive pharmaceutical supply agreement with DLA, which encompasses brand-name and generic medications, vaccines, and specialized medical supplies supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/10/25 |